Folifer

Quick links to important sections

Folifer

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folifer

Understanding Folifer

Folifer is a therapeutic preparation containing a combination of two essential nutrients: iron (usually in the form of dried ferrous sulfate) and folic acid (also known as vitamin B9). This combination is specifically formulated to address nutritional requirements and support the body's production of healthy red blood cells.

Core Components

  • Iron (Ferrous Sulfate): Iron is a vital mineral that serves as a primary building block for hemoglobin, the protein in red blood cells responsible for transporting oxygen from the lungs to the rest of the body.
  • Folic Acid: This water-soluble B vitamin is necessary for DNA synthesis and the division of cells. It works in tandem with iron to support erythropoiesis, the process by which the body generates new red blood cells.

Mechanism and Purpose

The primary purpose of Folifer is to supply the body with the necessary materials to maintain adequate blood levels and prevent or treat specific nutritional deficiencies. When the body does not have enough iron or folic acid, it cannot produce a sufficient amount of functional red blood cells, which can lead to a decrease in oxygen delivery to tissues.

By combining these two elements, Folifer addresses both the requirement for hemoglobin production and the cellular maturation process required for healthy blood function.

Regulatory References

  1. NIH, Folic Acid Fact Sheet

What side effects are possible with Folifer?

Possible Side Effects and Safety Information

Folifer (an iron and folic acid combination) is generally associated with a profile of gastrointestinal (GI) disturbances due to its iron content.

Adverse Reactions

Classification Common Adverse Reactions Rare/Serious Reactions
System-Organ Gastrointestinal disturbances (stomach upset, nausea, vomiting, constipation, diarrhea, abdominal pain, heartburn). Signs of a serious allergic reaction (anaphylaxis, angioedema) including rash, itching, severe dizziness, or difficulty breathing.
Stool Color Darkening or black discoloration of stools due to unabsorbed iron (harmless). Bloody or tarry stools, or vomit that resembles coffee grounds (requires immediate medical attention).

Safety Considerations and Restrictions

  • Hypersensitivity: Allergic sensitizations to folic acid have been reported. Immediate medical attention should be sought for any signs of severe allergic reaction.
  • Misdiagnosis Risk: Folic acid, in dosages above 0.1 mg daily, can mask the symptoms of Vitamin B12 deficiency (pernicious anemia) without preventing its neurological complications. Treatment should not be initiated until the underlying cause of anemia has been thoroughly investigated.
  • Overdose: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years of age. The product must be kept out of reach of children.
  • Contraindications: Use is contraindicated in patients with conditions involving iron overload (such as hemochromatosis or hemosiderosis) or certain types of anemia, including pernicious anemia and hemolytic anemia.

Overdose and Emergency Response

Overdose and When to Seek Help: Folifer

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children younger than 6 years. Overdose with Folifer, which contains iron, can be fatal, especially in a young child, and requires immediate emergency medical attention.


Documented Overdose Presentations

The clinical signs of a Folifer (iron) overdose can be delayed but often involve severe systemic toxicity. Key symptoms documented in regulatory information include:

  • Gastrointestinal Distress: Severe stomach pain, nausea, vomiting, bloody diarrhea, and coughing up blood or vomit that looks like coffee grounds.
  • Systemic Effects: Pale skin, blue lips, shallow breathing, seizure (convulsions), and signs of cardiovascular collapse such as a weak and rapid pulse.
  • Late-Stage Effects: Liver damage (hepatotoxicity) may develop several days following acute ingestion.

Emergency Response

If an overdose is suspected or has accidentally occurred, immediate action is mandatory. Get medical help right away or call a poison control center immediately, even if the symptoms appear minor or have not yet begun. Keep this product, and all iron-containing medications, out of the reach of children to prevent accidental ingestion. If the victim has collapsed, has trouble breathing, or has a seizure, immediately call emergency services (911 in the U.S. or the equivalent local number).

Therapeutic Uses of Folifer

What Folifer Treats: Main Uses and Benefits


The combination of iron and folic acid in Folifer is commonly used to help manage symptoms related to systemic imbalance that arise from deficiencies in these two essential micronutrients. This preparation is a therapeutic option for conditions characterized by periods of heightened symptoms associated with acute or disruptive episodes. The support provided is relevant for symptom management across key therapeutic domains. These components are fundamental to supporting blood health.

Key Therapeutic Applications

Folifer is applied across domains where additional symptomatic support is needed, primarily addressing nutritional anaemias, supporting health during the preconception phase and pregnancy, and assisting with restoration after depletion following chronic blood loss or surgical recovery. The support provided contributes to the management of symptoms like tiredness, generalized weakness, and low energy levels, which often interfere with daily functioning.

Contributes to easing the overall symptom load by supporting the replenishment of reserves when appropriate.”

During pregnancy, this use is commonly used for managing the heightened nutritional demands and assists with maintaining functional stability during symptomatic periods. This benefit helps ease the overall symptom burden.


Quick Fact: Relief for Anaemia-Related Fatigue

This combination is applied in addressing symptoms related to physical discomfort and systemic imbalance in situations where patients experience deficiency.

Regulatory References

  1. NIH MedlinePlus overview on Folate

Eligibility and Restrictions for Use

The eligibility for using Folifer (Iron and Folic Acid) is strictly defined by regulatory warnings and absolute contraindications related to its core ingredients.

Populations for Whom Use is Prohibited or Restricted

Category Regulatory Eligibility Status
Absolute Contraindications Use is prohibited in patients with iron overload disorders (such as hemochromatosis or hemosiderosis) and those with known hypersensitivity to any component [1.2, 1.5]. It is also contraindicated for patients with untreated Vitamin B12 deficiency (Pernicious Anemia), as the folic acid component can mask the hematological symptoms while neurological damage progresses [1.2].
Pediatric Safety Boundary Children under 6 years are subject to a major safety warning: the accidental overdose of iron-containing products is a leading cause of fatal poisoning in this age group [1.2]. Safety and effectiveness are not established for some formulations in younger pediatric patients [3.5].
Condition-Specific Restrictions The medicine is not recommended for patients whose anemia is not caused by iron deficiency (e.g., hemolytic anemia) [1.2]. Caution is required for patients with active gastrointestinal disorders (e.g., ulcerative colitis) and those receiving repeated blood transfusions [1.5].

Populations with Established Use

Category Regulatory Eligibility Status
Pregnancy and Lactation Pregnant individuals are explicitly permitted for use, and supplementation is often indicated to prevent and treat deficiencies due to increased physiological demand [4.1]. Use is also generally accepted for breastfeeding mothers [3.6].

Connection to the Eligibility Profile

The regulatory profile for Folifer is structured around the inherent risks of its components: iron toxicity and the potential for folic acid to obscure a severe neurological disorder [1.2, 1.5]. These strict, officially documented rules clearly determine that the drug is permissible only for adult and specific high-demand populations where deficiency is confirmed and contraindications are ruled out.

What should I know about interactions with other medicines?

Folifer's active ingredients, Iron and Folic Acid, have documented interaction patterns primarily concerning drug exposure and mutual antagonism, as defined in government regulatory labeling.

Documented Drug-Drug Interactions

The Iron component causes a pharmacokinetic interaction through chelation, significantly reducing the absorption and bioavailability of co-administered agents. This effect is documented for several substance classes, including Quinolone and Tetracycline Antibiotics, Bisphosphonates, and thyroid medications like Levothyroxine.

The Folic Acid component may cause pharmacodynamic antagonism. Official labeling states that Folic Acid has been reported to reduce the serum levels of certain Anticonvulsants (e.g., Phenytoin), potentially opposing their intended therapeutic action. Furthermore, high-dose Folic Acid can mutually inhibit the effects of antifolate agents such as Methotrexate.

Interaction-Related Restrictions

Interaction Type Interacting Substances Regulatory Constraint
Contraindicated Combination Eltrombopag Co-administration is formally restricted due to reduced exposure.
Timing Separation Antacids, Tetracyclines Mandatory separation of administration is required to prevent mutual absorption failure.
Food/Supplement Effect Dairy, Tea, Zinc, Calcium Officially documented to impair the oral absorption and bioavailability of the Iron component.

A population-specific caution noted in regulatory documents is that Folic Acid intake above 1 mg/day may mask the hematological signs of undiagnosed Vitamin B12 deficiency while allowing neurological complications to progress.

Mechanism of Action

Folifer delivers components that serve as precursors and cofactors in fundamental physiological pathways, engaging mechanisms within the hematopoietic system. This involves modulating enzymatic pathways critical for cell proliferation and oxygen transport.

Regulation of Erythropoiesis

This domain covers the role of Folifer's components, primarily iron and folic acid (Vitamin B9), within the bone marrow. Iron functions as a prosthetic group required for hemoglobin synthesis, the protein mediating oxygen binding in red blood cells (RBCs). Folic acid is converted into an active co-factor (tetrahydrofolate) vital for the de novo synthesis of DNA and RNA bases . This mechanism facilitates the terminal differentiation and maturation of erythrocytes, resulting in optimized oxygen-carrying capacity of the circulation.

Cofactor in Cellular Metabolism

Folic acid and, in some formulations, Vitamin B12, act as cofactors in the one-carbon metabolism cycle. This pathway is crucial for numerous metabolic reactions, including the methylation of homocysteine to methionine. Cofactor provision facilitates homeostatic regulation within targeted metabolic pathways, sustaining baseline cellular activity, and modulates the methylation status of lipids and proteins critical for membrane integrity in systems requiring rapid cell division.

Dosage and Administration Information

General Administration Principles

Folifer is administered through the oral route, typically provided as a tablet or capsule format containing the Iron and Folic Acid combination. Adherence to a standardized regimen is required, and use is managed under the direction and supervision of a licensed medical practitioner.

Dosing Patterns and Frequency

The specific dosing pattern is determined by the intended clinical use. For the treatment of manifest deficiencies, the regimen commonly involves taking one tablet or capsule twice daily, although certain preparations may specify up to three times daily. When used for prophylactic purposes, such as maintaining nutritional balance, the pattern is generally once daily.

Timing, Duration, and Population Use

To maximize the absorption of iron, the medicine is recommended to be taken on an empty stomach (e.g., one to two hours away from meals). However, clinical guidelines suggest consumption with food if the individual experiences gastrointestinal intolerance. For correction of manifest iron-deficiency anemia, the course of therapy typically lasts 3 to 5 months until the blood count normalizes. Treatment continuation for several additional weeks is often recommended to fully replenish iron stores, but generally does not extend beyond three months after the anemia is corrected. Specific formulations are generally not recommended for children under 12 years, but the standard adult dose is considered appropriate for older adults.

Recent Clinical Evidence

Folifer: Recent Clinical Evidence

This section summarizes clinical research concerning the compound (often referred to in combination with iron and folate for certain indications). This information is for educational purposes and is not a substitute for medical advice.


Clinical Study Overview

Studies of the compound, particularly in formulations containing iron and zinc (Folifer-Z), have focused on establishing bioequivalence and assessing outcomes in specific populations. Research involving iron replacement therapy, which may include this compound, addresses conditions like iron-deficiency anemia.

Key Research Areas

  • Bioequivalence Trials: A randomized controlled trial compared a sustained-release Folifer-Z tablet formulation against a reference product in healthy adult males. The study found the two formulations were therapeutically equivalent in terms of the rate and extent of absorption for both iron and zinc components.
  • Chronic Pain Management: While the primary approved use is for deficiency, other research has explored whether the compound interacts with certain pain-altering receptors in the body. However, strong clinical evidence for this mechanism in treating chronic pain remains limited in the public domain.
  • Safety Tracking: Clinical data collected during trials consistently tracked reported side effects. The most common adverse events related to injectable iron replacement include high blood pressure (hypertension), altered sense of taste, nausea, and localized reactions at the injection site (pain, swelling, redness).

Study Limitations

Many studies focus solely on the compound's role as a nutrient supplement in adults. Evidence regarding long-term effects, especially in combination with other drugs or in pediatric and severe chronic disease populations, continues to be an area of research with limited published data.

Frequently Asked Questions (FAQ)

Common questions about Folifer (FAQ)


Q: How quickly do people typically start to notice the intended effects of Folifer?

A: The course of therapy for correcting an iron deficiency is typically measured in months, not days or weeks. Official documents state that it may take 3 to 5 months until blood counts normalize. Treatment continuation is often recommended to fully replenish iron stores, but generally should not extend beyond three months after the anemia is corrected.


Q: Why is Folifer sometimes prescribed after surgery?

A: Folifer is designed to provide essential micronutrients when the body has an increased physiological demand. Official documentation states that the medicine may be used in situations involving increased physiological demand, such as those that follow blood loss.


Q: Is it normal to see changes in stool color while taking Folifer?

A: Yes, according to official product information, darkening or black discoloration of stools is a common and expected occurrence. This occurs due to unabsorbed iron content and is described in official safety information as a non-serious, expected effect.


Q: Are there any common digestive side effects reported with Folifer?

A: Regulatory documents indicate that the iron content of Folifer commonly causes various gastrointestinal disturbances. These reported adverse reactions can include stomach upset, nausea, constipation, diarrhea, or heartburn.


Q: Does taking Folifer affect the results of certain lab tests?

A: Yes, there is a specific safety warning in regulatory documents. Folic acid, if taken above a certain daily amount, may mask the signs of an undiagnosed Vitamin B12 deficiency while allowing neurological complications to progress without the underlying deficiency being treated.


Q: Is Folifer intended to treat a specific deficiency?

A: Folifer is classified as an antianemic agent because its purpose is to help the body restore deficient blood components. This specific combination is typically used to support individuals with iron-deficiency anemia.


Q: Are there warnings about taking Folifer with alcohol?

A: Regulatory guidance indicates that excessive consumption of alcohol may interfere with the folic acid component of the medicine. Alcohol may decrease its absorption and increase the rate at which it is eliminated from the body.


Q: Is Folifer known to affect sleep patterns?

A: Studies examining the high-dose Folic Acid component of this medicine have reported altered sleep patterns as a possible effect. These reports relate to the high-dose use of the component and may indicate potential central nervous system effects.


Q: Does Folifer interact with common pain relievers?

A: According to established interaction studies, Folifer has no known interaction with common over-the-counter pain relievers. This includes medications like acetaminophen or ibuprofen.


Q: Are there specific foods or drinks that should be avoided with Folifer?

A: Official documentation lists certain substances that can interfere with the iron component's absorption, such as dairy products, tea, and coffee. Official guidance documents state that separation of administration is required to prevent mutual absorption failure.


Q: Is Folifer appropriate for children?

A: Regulatory guidance generally does not recommend the use of this medicine for children under 12 years of age. Iron-containing products carry a regulatory safety warning: accidental overdose is a leading cause of fatal poisoning in young children.


Q: Is there information about Folifer's use in people with kidney issues?

A: Regulatory-linked research has specifically studied the role of the folic acid component in patients with kidney issues, particularly those undergoing renal dialysis. This research focuses on the component's effects on levels of certain substances in the body, such as homocysteine.


Q: Does Folifer contain any common allergens?

A: Reports of allergic sensitization (hypersensitivity) to the active component, folic acid, are noted in official documents. The full product documentation for any specific formulation lists inactive ingredients (excipients), which may include lactose or sulfites.


Q: Is Folifer gluten-free?

A: The active ingredients themselves, iron and folic acid, are documented as being gluten-free. However, the final gluten-free status of the tablet or capsule is determined by the inactive ingredients (excipients) used in that specific product’s formulation.


Q: What is the typical shelf life of Folifer tablets?

A: Regulatory documentation for tablets of this formulation type typically records a shelf life of 3 years when the medicine is maintained in the storage conditions specified on the label.


Q: Can Folifer cause a metallic taste?

A: Yes, official safety information indicates that a metallic or unpleasant taste has been reported as a potential side effect. This is associated with the oral iron component of the medicine.


Q: Do studies suggest Folifer is less effective if taken with dairy products?

A: Regulatory documentation explicitly states that dairy products impair the absorption and bioavailability of the iron component of Folifer. Regulatory documents indicate that separation from the administration of the medicine is required to prevent mutual absorption failure.


Q: Is it normal to feel a bit nauseous when first starting Folifer?

A: Nausea is listed in official documentation as a common adverse reaction associated with the iron content of this medicine. It is often experienced as the body adjusts to the supplementation.


Q: Does Folifer have a risk of overdose?

A: All iron-containing products carry a regulatory warning regarding the risk of accidental overdose. Accidental overdose is a leading cause of fatal poisoning in young children, and high doses in adults may cause severe effects.

How should Folifer be stored and disposed of?

Storage and Disposal Requirements

Official regulatory labeling dictates specific conditions for storing and disposing of Folifer (Iron/Folic Acid tablets).


Storage Conditions

The medicine must be stored at room temperature, typically not exceeding 25 C to 30 C (77 F to 86 F). It must be kept away from excess heat, moisture, and light. To maintain stability and product integrity, the tablets must remain in the original container, kept tightly closed.

Child-Safety and Handling

All iron-containing products carry a serious regulatory warning: Accidental overdose of iron is a leading cause of fatal poisoning in young children. The medication must be stored out of the sight and reach of children and pets, utilizing the child-resistant closure at all times.

Disposal Instructions

Expired or unneeded Folifer must not be flushed down the toilet. The preferred method of disposal is through a community drug take-back program. If a take-back option is unavailable, the medicine must be mixed with an undesirable substance (like coffee grounds or dirt) and placed in a sealed container before being thrown in the household trash, following environmental protection guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Folifer found in:

A-Z Index: